Item 1. Financial Statements
ITEM 1. FINANCIAL STATEMENTS
Loop Industries, Inc.
Three months ended May 31, 2022
Index to the Unaudited Interim Condensed Consolidated Financial Statements
Contents
Page(s)
Condensed consolidated balance sheets as at May 31, 2022 and February 28, 2022 (Unaudited)
F‑2
Condensed consolidated statements of operations and comprehensive loss for the three months ended May 31, 2022 and 2021 (Unaudited)
F‑3
Condensed consolidated statement of changes in stockholders’ equity for the three months ended May 31, 2022 and 2021 (Unaudited)
F‑4
Condensed consolidated statement of cash flows for the three months ended May 31, 2022 and 2021 (Unaudited)
F‑5
Notes to the condensed consolidated financial statements (Unaudited)
F‑6
F-1
Table of Contents
Loop Industries, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
As at
May 31,
2022
February 28,
2022
Assets
Current assets
Cash and cash equivalents
$ 32,400,737
$ 44,061,427
Sales tax, tax credits and other receivables (Note 3)
1,126,151
1,716,262
Prepaid expenses and deposits (Note 4)
3,773,125
2,965,646
Assets held for sale (Note 5)
3,402,677
3,389,279
Total current assets
40,702,690
52,132,614
Investment in joint venture
380,922
380,922
Property, plant and equipment, net (Note 6)
5,580,748
5,692,862
Intangible assets, net (Note 7)
1,067,398
1,013,801
Total assets
$ 47,731,758
$ 59,220,199
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable and accrued liabilities (Note 9)
$ 7,849,416
$ 9,846,815
Current portion of long-term debt (Note 10)
129,889
-
Total current liabilities
7,979,305
9,846,815
Long-term debt (Note 10)
3,301,869
3,378,403
Total liabilities
11,281,174
13,225,218
Stockholders' Equity
Series A Preferred stock par value $ 0.0001 ; 25,000,000 shares authorized; one share issued and outstanding
-
-
Common stock par value $ 0.0001 ; 250,000,000 shares authorized; 47,400,709 shares issued and outstanding (February 28, 2022 – 47,388,056 ) (Note 12)
4,741
4,740
Additional paid-in capital
158,863,011
150,396,704
Additional paid-in capital – Warrants
30,272,496
30,272,496
Accumulated deficit
( 152,588,865 )
( 134,582,926 )
Accumulated other comprehensive loss
( 100,799 )
( 96,033 )
Total stockholders' equity
36,450,584
45,994,981
Total liabilities and stockholders' equity
$ 47,731,758
$ 59,220,199
See accompanying notes to the condensed consolidated financial statements .
F-2
Table of Contents
Loop Industries, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
Three Months Ended
May 31,
2022
May 31,
2021
Revenue
$ -
$ -
Expenses :
Research and development (Note 13)
6,800,484
8,637,905
General and administrative (Notes 14)
11,036,641
3,160,571
Depreciation and amortization (Notes 6 and 7)
138,541
132,001
Interest and other financial expenses (Note 18)
41,329
30,588
Interest income
( 13,193 )
( 9,761 )
Foreign exchange loss
2,137
206,060
Total expenses
18,005,939
12,157,364
Net loss
( 18,005,939 )
( 12,157,364 )
Other comprehensive loss -
Foreign currency translation adjustment
( 4,766 )
206,815
Comprehensive loss
$ ( 18,010,705 )
$ ( 11,950,549 )
Net Loss per share
Basic and diluted
$ ( 0.38 )
$ ( 0.29 )
Weighted average common shares outstanding
Basic and diluted
47,400,571
42,433,107
See accompanying notes to the condensed consolidated financial statements.
F-3
Table of Contents
Loop Industries, Inc.
Condensed Consolidated Statement of Changes in Stockholders’ Equity
(Unaudited)
Three months ended May 31, 2021
Common stock
Preferred stock
Additional
Accumulated Other
par value $0.0001
par value $0.0001
Additional
Paid-in
Comprehensive
Total
Number of Shares
Amount
Number of Shares
Amount
Paid-in
Capital
Capital – Warrants
Accumulated Deficit
Income
(Loss)
Stockholders’ Equity
Balance, February 28, 2021
42,413,691
$ 4,242
1
$ -
$ 113,662,677
$ 8,826,165
$ ( 89,661,970 )
$ ( 6,590 )
$ 32,824,524
Issuance of shares upon the vesting of restricted stock units (Note 15)
19,629
2
-
-
( 2 )
-
-
-
-
Stock options issued for services (Note 15)
-
-
-
-
549,318
-
-
-
549,318
Restricted stock units issued (forfeited) for services (Note 15)
-
-
-
-
( 548,961 )
-
-
-
( 548,961 )
Foreign currency translation
-
-
-
-
-
-
-
206,815
206,815
Net loss
-
-
-
-
-
-
( 12,157,364 )
-
( 12,157,364 )
Balance, May 31, 2021
42,433,320
$ 4,244
1
$ -
$ 113,663,032
$ 8,826,165
$ ( 101,819,334 )
$ 200,225
$ 20,874,332
Three months ended May 31, 2022
Common stock
Preferred stock
Additional
Accumulated Other
par value $0.0001
par value $0.0001
Additional
Paid-in
Comprehensive
Total
Number of Shares
Amount
Number of Shares
Amount
Paid-in
Capital
Capital – Warrants
Accumulated Deficit
Income
(Loss)
Stockholders’ Equity
Balance, February 28, 2022
47,388,056
$
4,740
1
$
-
$
150,396,704
$
30,272,496
$
( 134,582,926 )
$
( 96,033 )
$
45,994,981
Issuance of shares upon the vesting of restricted stock units (Note 15)
12,653
1
-
-
( 1 )
-
-
-
-
Stock options issued for services (Note 15)
-
-
-
-
317,140
-
-
-
317,140
Restricted stock units issued for services (Note 15)
-
-
-
-
8,149,168
-
-
-
8,149,168
Foreign currency translation
-
-
-
-
-
-
-
( 4,766 )
( 4,766 )
Net loss
-
-
-
-
-
-
( 18,005,939 )
-
( 18,005,939 )
Balance, May 31, 2022
47,400,709
$
4,741
1
$
-
$
158,863,011
$
30,272,496
$
( 152,588,865 )
$
( 100,799 )
$
36,450,584
See accompanying notes to the condensed consolidated financial statements.
F-4
Table of Contents
Loop Industries, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended May 31,
2022
2021
Cash Flows from Operating Activities
Net loss
$ ( 18,005,939 )
$ ( 12,157,364 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization (Notes 6 and 7)
138,541
132,001
Stock-based compensation expense (Note 15)
8,466,307
15,357
Accretion and accrued interest expenses (Note 18)
39,794
21,408
Changes in operating assets and liabilities:
Sales tax and tax credits receivable (Note 3)
593,931
287,116
Prepaid expenses (Note 4)
( 796,491 )
( 1,326,519 )
Accounts payable and accrued liabilities (Note 9)
( 2,012,387 )
622,443
Net cash used in operating activities
( 11,576,244 )
( 12,405,558 )
Cash Flows from Investing Activities
Additions to property, plant and equipment (Note 6)
-
( 4,867,007 )
Additions to intangible assets (Note 7)
( 69,247 )
( 52,319 )
Net cash used in investing activities
( 69,247 )
( 4,919,326 )
Cash Flows from Financing Activities
Repayment of long-term debt (Note 10)
-
( 14,496 )
Net cash (used) provided by financing activities
-
( 14,496 )
Effect of exchange rate changes
( 15,199 )
154,491
Net decrease in cash
( 11,660,690 )
( 17,184,889 )
Cash, beginning of period
44,061,427
35,221,951
Cash, end of period
$ 32,400,737
$ 18,037,062
Supplemental Disclosure of Cash Flow Information:
Income tax paid
$ -
$ -
Interest paid
$ -
$ 9,178
Interest received
$ 13,193
$ 9,761
See accompanying notes to the condensed consolidated financial statements.
F-5
Table of Contents
Loop Industries, Inc.
Three Months Ended May 31, 2022 and 2021
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
1. The Company and Basis of Presentation
The Company
Loop Industries, Inc. (the “Company,” “Loop,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber. The Company is currently in the development stage with no revenues.
Basis of Presentation
These unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2022, filed with the SEC on May 27, 2022. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50 % interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.
Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 28, 2022, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by US GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three months ended May 31, 2022 are not necessarily indicative of the results to be expected for any subsequent quarter, for the fiscal year ending February 28, 2023, or for any other period.
The consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the continuing of operations, the realization of assets and the settlement of liabilities in the normal course of business.
2. Summary of Significant Accounting Policies
Liquidity Risk Assessment
From inception to May 31, 2022, the Company has been in the development stage with no revenues, and with its ongoing operations and commercialization plans financed primarily by raising equity. The Company has incurred net losses and negative cash flow from operating activities since its inception and expects to incur additional net losses while it continues to develop and plan for commercialization. As at May 31, 2022, the Company has cash and cash equivalents of $ 32.40 million. Management actively monitors the Company’s cash resources against the Company’s short-term cash commitments to ensure the Company has sufficient liquidity to fund its costs for at least twelve months from the financial statement issuance date. Management evaluates the Company’s liquidity to determine if there is substantial doubt about the Company’s ability to continue as a going concern. In preparing this liquidity assessment, management applies significant judgment in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to: (i) estimation of amount and timing of future cash outflows and cash inflows and (ii) determining what future expenditures are committed and what could be considered discretionary. Based on this assessment, management believes that the Company will be able to realize its assets and discharge its liabilities in the normal course of operations as they become due for a period of no less than twelve months from the date of issuance of these consolidated financial statements.
F-6
Table of Contents
The company is currently evaluating financing options to move to the next stage of its strategic development and construct manufacturing plants in Canada, Europe and Asia. Our ability to successfully commercialize our business and generate future revenues depends on whether we can obtain the necessary financing through a combination of the issuance of debt, equity, and/or joint ventures and/or government incentive programs. We have committed a portion of our cash resources for certain long lead equipment in connection with the Bécancour project. We may enter into additional commitments to move the project ahead within our targeted construction timeframes. However, there is no assurance that the Company will be successful in attracting additional funding. Even if additional financing is available, it may not be available on terms favorable to us. Our failure to secure additional financing on favorable terms when it becomes required would have an adverse effect on our current operation and on our ability to execute our business plan.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include the going concern assessment, estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets as well as the carrying value of our joint venture investment, assets held for sale, accruals for potential liabilities, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards.
The COVID-19 pandemic, as well as supply chain and geo-political disruptions, have affected business operations and planning for future commercial facilities to varying degrees for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these conditions has had and may continue to have an effect on our development and commercialization efforts.
Stock‑based compensation
The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and recognized as compensation expense on the straight-line basis over the vesting period. When performance conditions exist, the Company recognizes compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.
The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.
The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.
The fair value of the stock options granted is estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods.
F-7
Table of Contents
Research and development expenses
Research and development costs are charged to expense as costs are incurred in performing research and development activities. Research and development expenses relate primarily to process development and design, testing of pre-production samples, machinery and equipment expenditures for use in the small-scale production facility in Terrebonne, Québec (the “Terrebonne Facility”), compensation, and consulting and engineering fees.
Assets held for sale
Assets are classified as held for sale when they met the criteria set out in ASC 360-10-45-9 Long-lived assets classified as held for sale :
·
Management, having the authority to approve the action, commits to a plan to sell the asset;
·
The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;
·
An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated;
·
The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year;
·
The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and
·
Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
When the criteria are met, the assets are presented at the lesser of fair market value, net of selling costs, and cost in current assets.
Foreign currency translations and transactions
The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently is not engaged in any currency hedging activities.
For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.
Net earnings (loss) per share
The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share . Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.
For the three-month periods ended May 31, 2022 and 2021, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at May 31, 2022, the potentially dilutive securities consisted of 1,570,000 outstanding stock options (2021 – 1,587,081 ), 4,090,775 outstanding restricted stock units (2021 – 4,149,125 ), and 11,659,418 outstanding warrants (2021 – 4,133,720 ).
F-8
Table of Contents
Recently adopted accounting pronouncements
In November 2021, the FASB issued ASU 2021-10, “Disclosures by Business Entities about Government Assistance”. This ASU provided guidance to increase the transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. Under the new guidance, an entity is required to provide the following annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy: (1) information about the nature of the transactions and the related accounting policy used to account for the transactions, (2) the line items on the balance sheet and income statement that are affected by the transactions, and the amounts applicable to each financial statement line item and, (3) significant terms and conditions of the transactions, including commitments and contingencies. This update is effective for fiscal years beginning after December 15, 2021. The adoption of this accounting guidance did not impact our Consolidated Financial Statements and disclosures.
3. Sales Tax, Tax Credits and Other Receivables
Sales tax, research and development tax credits and other receivables as at May 31, 2022 and February 28, 2022 were as follows:
May 31, 2022
February 28, 2022
Sales tax
$ 679,490
$ 1,337,783
Research and development tax credits
431,688
313,599
Other receivables
14,973
64,880
$ 1,126,151
$ 1,716,262
4. Prepaid Expenses and Deposits
Prepaid expenses and deposits as at May 31, 2022 and February 28, 2022 were as follows:
May 31, 2022
February 28, 2022
Directors and officers insurance
$ 904,699
$ -
Deposits on machinery and equipment
2,728,910
2,801,680
Other
139,516
163,966
$ 3,773,125
$ 2,965,646
As at May 31, 2022, the Company had $ 2,728,910 (February 28, 2022 – $ 2,801,680 ) of non-refundable cash deposits on machinery and equipment. $ 593,602 (February 28, 2022 – $ 672,713 ) of the prepayments are on machinery and equipment that will be used in connection with the research and development activities at the Terrebonne Facility and will be expensed, and classified as research and development expenses in the period the equipment is received. The remainder of the prepayments of $ 2,135,308 (February 28, 2022 –$ 2,128,967 ) are non-refundable cash deposits on long-lead machinery and equipment that will be used in the planned Infinite Loop ™ manufacturing facility in Bécancour, Québec.
5. Asset held for sale
On May 27, 2021, we acquired land in Bécancour, Québec for cash of $ 4.8 million (CDN $5.9 million) , for which a portion of the land is the site of our planned Infinite Loop ™ manufacturing facility. The excess land has been classified as an asset held for sale, on the basis that management is committed to a plan to dispose of the excess land and believes the sale is probable within one year.
The total purchase cost of the land has been allocated between the portion of land held for sale and the land being used for the Infinite Loop ™ manufacturing facility based on surface area.
Description
Balance sheet line item
Cost
Land held for sale
Asset held for sale
$ 3,402,677
Infinite Loop ™ manufacturing facility
Property, plant and equipment, net
1,407,400
$ 4,810,077
F-9
Table of Contents
6. Property, Plant and Equipment
As at May 31, 2022
Cost
Accumulated depreciation, write-down and impairment
Net book value
Building
$ 1,960,062
$ ( 283,814 )
$ 1,676,248
Land
1,650,584
-
1,650,584
Building and Land Improvements
3,044,871
( 959,879 )
2,084,992
Office equipment and furniture
301,997
( 133,073 )
168,924
$ 6,957,514
$ ( 1,376,766 )
$ 5,580,748
As at February 28, 2022
Cost
Accumulated depreciation, write-down and impairment
Net book value
Building
$ 1,952,345
$ ( 266,434 )
$ 1,685,911
Land
1,644,084
-
1,644,084
Building and Land Improvements
3,049,892
( 858,342 )
2,191,550
Office equipment and furniture
298,141
( 126,824 )
171,317
$ 6,944,462
$ ( 1,251,600 )
$ 5,692,862
Depreciation expense for the three-month periods ended May 31, 2022 and 2021 amounted to $ 119,093 and $ 115,057 , respectively, and is recorded as an operating expense in the consolidated statements of operations and comprehensive loss.
During the three-month period ended May 31, 2021, the Company acquired a 19 million square foot parcel of land in Bécancour, Québec for $ 4.8 million (CDN $5.9 million). The Company intended use for the site is to construct a commercial facility to manufacture Loop™ branded PET resin using its Infinite Loop™ technology.
7. Intangible Assets
Intangible assets as at May 31, 2022 and February 28, 2022 were $ 1,067,398 and $ 1,013,801 , respectively.
During the three-month periods ended May 31, 2022 and 2021, we made additions to intangible assets of $ 69,247 and $ 52,319 , respectively.
Amortization expense for the three-month periods ended May 31, 2022 and 2021 amounted to $ 19,539 and $ 16,944 , respectively, and is recorded as an operating expense in the unaudited condensed consolidated statements of operations and comprehensive loss.
F-10
Table of Contents
8. Fair Value of Financial Instruments
The following tables presents the fair value of the Company’s financial liabilities as at May 31, 2022 and February 28, 2022:
Fair Value as at May 31, 2022
Carrying
Amount
Fair Value
Level in the hierarchy
Financial liabilities measured at amortized cost:
Long-term debt
3,431,758
3,445,328
Level 2
Fair Value as at February 28, 2022
Carrying
Amount
Fair Value
Level in the hierarchy
Financial liabilities measured at amortized cost:
Long-term debt
$ 3,378,403
$ 3,392,600
Level 2
The fair value of cash, sales tax, tax credits and other receivables, and accounts payable and accrued liabilities approximate their carrying values due to their short-term maturity.
9. Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities as at May 31, 2022 and February 28, 2022 were as follows:
May 31, 2022
February 28, 2021
Trade accounts payable
$ 3,613,904
$ 4,397,499
Accrued loss contingency for legal settlement (Note 18)
2,230,759
2,519,220
Accrued employee compensation
1,030,097
1,254,685
Accrued engineering fees
354,491
774,423
Accrued professional fees
298,133
526,685
Other accrued liabilities
322,032
374,303
$ 7,849,416
$ 9,846,815
10. Long‑Term Debt
Long-term debt as of May 31, 2022 and February 28, 2022, was comprised of the following:
May 31, 2022
February 28, 2022
Investissement Québec financing facility :
Principal amount
$ 3,636,939
$ 3,622,618
Unamortized discount
( 335,753 )
( 352,038 )
Accrued interest
130,572
107,823
Total Investissement Québec financing facility
3,431,758
3,378,403
Less: current portion of long-term debt
( 129,889 )
-
Long-term debt, net of current portion
$ 3,301,869
$ 3,378,403
Investissement Québec financing facility
The Company recorded interest expense on the Investissement Québec loan for the three-month period ended May 31, 2022 in the amount of $ 22,208 (2021 – $ 10,882 ) and an accretion expense of $ 17,586 (2021 – $ 10,526 ).
Principal repayments due on the Company’s bank indebtedness over the next five years are as follows:
Years ending
Amount
February 28, 2023
$ -
February 29, 2024
519,554
February 28, 2025
519,554
February 28, 2026
519,554
February 28, 2027
519,554
Thereafter
1,558,723
Total
$ 3,636,939
F-11
Table of Contents
11. Related Party Transactions
Employment Agreement
On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term.
On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units (“RSUs”) covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan. Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.
On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement. The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic that is far simpler to purify. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $ 7.74 per share.
During the three-month period ended May 31, 2022, Mr. Solomita met a performance milestone in relation to the signature of a supply agreement with a customer. Accordingly, 1,000,000 performance incentive RSUs with a fair value of $ 7,740,000 were earned and issuable to Mr. Solomita. This amount was reflected as stock-based compensation expense during the three-month period ended May 31, 2022 based on the grant date fair value. The 1,000,000 vested RSU’s are to be settled annually on October 15 of each year in five equal tranches of 200,000 units.
12. Stockholders’ Equity
Common Stock
For the period ended May 31, 2022
Number of shares
Amount
Balance, February 28, 2022
47,388,056
$ 4,740
Issuance of shares upon settlement of restricted stock units
12,653
1
Balance, May 31, 2022
47,400,709
$ 4,741
For the period ended May 31, 2021
Number of shares
Amount
Balance, February 28, 2021
42,413,691
$ 4,242
Issuance of shares upon settlement of restricted stock units
19,629
2
Balance, May 31, 2021
42,433,320
$ 4,244
During the three months ended May 31, 2022, the Company recorded the following common stock transaction:
(i)
The Company issued 12,653 shares of the common stock to settle restricted stock units that vested in the period.
During the three months ended May 31, 2021, the Company recorded the following common stock transaction:
(i)
The Company issued 19,629 shares of the common stock to settle restricted stock units that vested in the period.
F-12
Table of Contents
13. Research and Development Expenses
Research and development expenses for the three-month periods ended May 31, 2022 and 2021 were as follows:
May 31, 2022
May 31, 2021
External engineering
$ 1,595,614
$ 2,903,448
Employee compensation
2,287,341
2,086,128
Machinery and equipment expenditures
1,889,656
2,622,892
Plant and laboratory operating expenses
744,541
691,537
Other
283,332
333,900
$ 6,800,484
$ 8,637,905
14. General and Administrative Expenses
General and administrative expenses for the three-month periods ended May 31, 2022 and 2021 were as follows:
May 31, 2022
May 31, 2021
Professional fees
$ 798,983
$ 1,631,451
Employee compensation (1)
8,784,553
461,405
Insurance
1,102,541
868,647
Other
350,564
199,068
$ 11,036,641
$ 3,160,571
_________________
(1)
Includes stock-based compensation expense. During the three-month period ended May 31, 2022, the Company recorded a stock-based compensation expense of $ 7,740,000 related to the achievement of a performance milestone for 1,000,000 RSUs granted to the Company’s CEO, Daniel Solomita (Note 11). During the three-month period ended May 31, 2021, the Company accounted for RSU forfeitures for an amount of $ 935,837 as a reversal of stock-based compensation.
15. Share-based Payments
Stock Options
During the three-month period ended May 31, 2022, the Company granted no stock options (2021 – nil), no stock options were forfeited (2021 – nil) or exercised (2021 – nil) and no stock options expired (2021 – nil).
The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. There were no new issuances of stock options for the three-month periods ended May 31, 2022 and 2021.
The total number of stock options outstanding as at May 31, 2022 was 1,570,000 (2021 – 1,587,081 ) with a weighted average exercise price of $ 6.87 (2021 – $ 6.81 ), of which 1,336,667 were exercisable (2021 – 1,229,998 ) with a weighted average exercise price of $ 7.65 (2021 – $ 7.25 ).
During the three-month periods ended May 31, 2022 and 2021, stock-based compensation expense attributable to stock options amounted to $ 317,140 and $ 549,318 , respectively, and is included in operating expenses.
F-13
Table of Contents
Restricted Stock Units
During the three-month period ended May 31, 2022, the Company granted 84,861 restricted stock units (“RSUs”) (2021 – 253,758 ) with a weighted average fair value of $ 6.00 (2021 – $ 8.85 ), settled 12,653 RSUs (2021 – 19,629 ) with a weighted average fair value of $ 13.04 (2021 – $ 9.02 ) and no RSUs were forfeited (2021 – 295,524 with a weighted average fair value of $ 7.93 ).
The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.
The total number of RSUs outstanding as at May 31, 2022 was 4,090,775 (2021 – 4,149,125 ), of which 1,530,313 were vested (2021 – 696,327 ).
During the three-month periods ended May 31, 2022 and 2021, stock-based compensation attributable to RSUs amounted to $ 8,149,168 and ($ 533,961 ), respectively, and is included in operating expenses. During the three-month period ended May 31, 2022, the Company recorded a stock-based compensation expense of $ 7,740,000 related to the achievement of a performance milestone for 1,000,000 RSUs granted to the Company’s CEO, Daniel Solomita (Note 11). The net reversal in expenses attributable to RSUs in the three-month period ended May 31, 2021 was due to forfeitures accounted for in the period for a total of $ 935,837 .
Stock-Based Compensation Expense
During the three-month periods ended May 31, 2022 and 2021, stock-based compensation included in research and development expenses amounted to $ 396,495 and $ 395,545 , respectively, and in general and administrative expenses amounted to $ 8,069,813 and ($ 380,188 ), respectively. The amount recorded in general and administrative expenses for the three-month period ended May 31, 2022 includes $ 7,740,000 related to the achievement of a performance milestone for 1,000,000 RSUs granted to the Company’s CEO, Daniel Solomita (Note 11). The net reversal in stock-based compensation included in general and administrative expenses in the three-month period ended May 31, 2021 was due to forfeitures accounted for in the period for a total of $935,837.
16. Equity Incentive Plan
On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5 % of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2022 and 2021, the Board of Directors opted to waive the annual share reserve increase. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10 % of the voting power of the Company, the life of the options shall not exceed 5 years.
The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the three-month periods ended May 31, 2022 and 2021:
2022
2021
Number of
units
Number of
units
Outstanding, beginning of period
1,043,705
1,083,412
Automatic share reserve increase
-
-
Units granted
( 84,861 )
( 253,758 )
Units forfeited
-
295,524
Units expired
-
-
Outstanding, end of period
958,844
1,125,178
17. Interest and Other Financial Expenses
Interest and other financial expenses for the three-month periods ended May 31, 2022 and 2021 are as follows:
2022
2021
Interest on long-term debt
$ 22,208
$ 20,059
Accretion expense
17,586
10,529
Other
1,535
-
$ 41,329
$ 30,588
F-14
Table of Contents
18. Commitments and Contingencies
Agreement to purchase of machinery and equipment
In December 2021, the Company entered into an agreement for the purchase of long lead machinery and equipment in connection with the construction of our Infinite Loop ™ manufacturing facility in Bécancour, Québec for up to $ 8,546,000 over the next 9 months, subject to various terms and conditions. Pursuant to the agreement, the Company has paid a cash deposit of $ 2,136,500 .
Contingencies
On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti , Case No. 7:20-cv-0838-NSR (“Tremblay Class Action”). The complaint alleges that the defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The complaint seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.
On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti , Case No. 7:20-cv-09031-NSR. The complaint allegations are similar in nature to those in the Tremblay Class Action.
On January 4, 2021, the United States District Court for the Southern District of New York consolidated the two proposed class-action lawsuits as In re Loop Industries, Inc. Securities Litigation , Master File No. 7:20-cv-08538-NSR. Sakari Johansson and John Jay Cappa were appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP were appointed as Co-Lead Counsel for the class.
Plaintiffs served a consolidated amended complaint on February 18, 2021, which alleges that the defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relies on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021.
On March 1, 2022, the Company and the current and former officer defendants entered into an agreement for the settlement of the Tremblay Class Action, and, on March 4, 2022, advised the Court of the agreement to settle. The agreement, which is subject to certain conditions, including court approval, requires the Company to pay $ 3.1 million to the plaintiff class. The Company’s total cash contribution to the settlement and outstanding legal fees related to the lawsuit, combined, will be approximately $ 2.52 million. The remainder of the settlement will be paid by the Company’s D&O insurance carriers. As a result, the Company recorded a contingency loss of $ 2,519,220 which was included in accounts payable and accrued liabilities at February 28, 2022. As at May 31, 2022, the amount included in accounts payable and accrued liabilities related to the settlement was $ 2,230,759 . The accrued loss contingency for legal settlement was reduced by legal costs incurred in the three-month period ended May 31, 2022 of $ 288,461 .
On May 24, 2022, Lead Plaintiffs filed their motion for preliminary approval of the proposed class action settlement. The motion is pending before the Court.
The settlement agreement does not constitute an admission, concession, or finding of any fault, liability, or wrongdoing by the Company or any defendant.
On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations. The authorization hearing was held on February 24, 2022 and the matter is currently under advisement.
Management believes that this case lacks merit and intends to defend it vigorously. No amounts have been provided for in the consolidated financial statements with respect to this claim. Management has not yet determined what effect this lawsuit may have on its financial position or results of operations as it is still in the preliminary stages.
F-15
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.